Home
Investment Rounds
Cognito Therapeutics Series C 2026

Loading investment round...

The leading intelligence layer for the startup ecosystem. Over 25,000 AI startups, curated, scored, and agent-ready, backed by 14,000+ investors, 75,000+ people and 24,000+ funding rounds you can query in real time through our RAG API.

DR64Ahrefs DR: 64/100. Above median. Measured by Ahrefs. Median 44.·

eDR82Effective DR: 82/100. Above median. Measured by StartupHub.ai. Median 68.·

Agent94Agent Readiness: 94/100. Top 25%. Measured by StartupHub.ai. Median 41.·

Trust99Data Trust: 99/100. Top 25%. Measured by StartupHub.ai. Median 61.·

API91API & MCP Security: 91/100. Measured by StartupHub.ai.our own scores, refreshed daily

Questions or support: Help and contact

Product

Startups
Investors
Rankings
Trending
Watchlist
Pricing
Price match

Tools

Free Tools
Article to YouTube
Agent Readiness
Email Validator
API Docs
MCP Server

Company

About
Contact
AI News
Blog
How-to guides
Write for Us
Advertise

Legal

Privacy Policy
Terms
Affiliate Disclosure
security.txt
Sitemap
RSS

© 2026 StartupHub.ai. All rights reserved.

StartupHub.ai

Discover

Home
Search
Submit Profile
News
Videos
Jobs

Browse

Rankings
New Startups
Market Analysis
Comparison
Watchlist

Tools

Email Validator
DR Checker
Agent Readiness
Market Map Maker
All Free Tools

Company

Pricing
Advertise
API Docs
About
Publish Content

Cognito Therapeutics Series C

Cognito Therapeutics Series C header image

Cognito Therapeutics Series C

2011Boston, Massachusetts, USA

Cognito Therapeutics

Profile section

About

Cognito Therapeutics has secured $105 million in an oversubscribed Series C funding round. The company is developing its Spectris™ neuromodulation device for the treatment of Alzheimer's disease. This funding will accelerate the advancement of their platform and clinical programs.

Round details

Amount$105M

SeriesSeries C

AnnouncedMar 5, 2026

Tags

BiotechnologyMachine LearningUSA

Source

Round announcement

businesswire.com

Round score

55/100

Solid

A solid round with healthy fundamentals.

Round size vs peers
Larger than the typical Series C round (2.1×).

Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.

vs. Series C rounds (200)

Round size distribution77th pct

smaller Series C roundslarger

vs. Biotechnology (188)

Round size in sector86th pct

$160Kthis round: $105M$130M

Cognito Therapeutics Series C · $105M raised · (2026)